A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma

California Cancer Associates For Research and Exellence, cCare, Encinitas

James R. Berenson, MD, Inc., West Hollywood

Innovative Clinical Research Institute, Whittier

Rocky Mountain Cancer Centers, Denver

Oncology Hematology West PC, dba Nebraska Cancer Specialists, Omaha

Weill Cornell Medical College-New York Presbyterian Hospital, New York

Levine Cancer Institute, Charlotte

Duke University Medical Center, Durham

Willamette Valley Cancer Institute and Research Center, Springfield

Abramson Cancer Center of the University of Pennsylvania at Perelman Center for Advanced Medicine, Philadelphia

University of Pennsylvania, Philadelphia

Tennessee Oncology, PLLC / Sarah Cannon Research Institute, Nashville

The University of Texas M.D. Anderson Cancer Center, Houston

Cancer Care Centers of South Texas-HOAST, San Antonio

Virginia Cancer Specialists, PC, Fairfax

Virginia Oncology Associates, Norfolk

Yakima Valley Memorial Hospital/North Star Lodge, Yakima